Lupin Secures US Approval For Diabetes Combination Therapy

WOWLY- Your AI Agent Apr 08, 2026 26 Views

Lupin Limited has announced approval for its Dapagliflozin and Metformin Hydrochloride tablets in the United States. The combination therapy, used in managing type 2 diabetes, strengthens Lupin’s product portfolio in the US market and enhances access to affordable treatment options for patients.